![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 17, 11611-11618, April 23, 1999
B Activation and Tumor Necrosis
Factor Expression by Inhibiting I
B Phosphorylation and Subsequent
Proteolysis
,
,
,
,
,
,
, and
From the Extensively oxidized low density lipoprotein
(ox-LDL), a modulator of atherogenesis, down-regulates the
lipopolysaccharide (LPS)-induced activation of transcription factor
NF-
Institute of Clinical Chemistry and
Pathobiochemistry, Klinikum rechts der Isar, Technical University
Munich, Ismaninger Strasse 22, 81675 München, Germany, the
¶ Department of Bioorganic Chemistry, Max-Planck-Institute of
Biochemistry, Am Klopferspitz 18a, 82152 Martinsried, Germany, the
Institute of Biochemistry, University of Graz,
Schubertstrasse 1, 8010 Graz, Austria, and the ** Institute for
Immunology, Ludwig-Maximilians-University Munich, Goethestrasse 31, 80336 München, Germany
B. We investigated whether 4-hydroxynonenal (HNE), a prominent
aldehyde component of ox-LDL, represents one of the inhibitory
substances. NF-
B activation by stimuli such as LPS, interleukin
(IL)-1
, and phorbol ester, but not tumor necrosis factor (TNF), was
reversibly inhibited by HNE in a dose-dependent manner in
human monocytic cells, whereas AP-1 binding was unaffected. Using
similar HNE concentrations, LPS-induced
B- and TNF or IL-8
promoter-dependent transcription was prevented.
Furthermore, pretreatment with HNE suppressed TNF production but not
lactate dehydrogenase levels. Under these conditions the binding of LPS
to monocytic cells was not significantly affected. However, induced
proteolysis of the inhibitory proteins I
B-
, I
B-
, and, at a
later time point, I
B-
was prevented. This is not due to
inhibition of the proteasome, the major proteolytic activities of which
remain unaffected, but rather to a specific prevention of the
activation-dependent phosphorylation of I
B-
. This is
the first report which demonstrates that HNE specifically inhibits the
NF-
B/Rel system. Down-modulation of NF-
B-regulated gene
expression may contribute at certain stages of atherosclerosis to low
levels of chronic inflammation and may also be involved in other
inflammatory/degenerative diseases.
This article has been cited by other articles:
![]() |
G. Sethi, B. Sung, and B. B. Aggarwal Nuclear Factor-{kappa}B Activation: From Bench to Bedside Experimental Biology and Medicine, January 1, 2008; 233(1): 21 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.C. Huth, B. Saugel, F.M. Jakob, C. Cappello, M. Quirling, E. Paschos, K. Ern, R. Hickel, and K. Brand Effect of Aqueous Ozone on the NF-{kappa}B System J. Dent. Res., May 1, 2007; 86(5): 451 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cappello, B. Saugel, K. C. Huth, A. Zwergal, M. Krautkramer, C. Furman, M. Rouis, B. Wieser, H. W. Schneider, D. Neumeier, et al. Ozonized Low Density Lipoprotein (ozLDL) Inhibits NF-{kappa}B and IRAK-1-Associated Signaling Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 226 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Farooqui and L. A. Horrocks Phospholipase A2-Generated Lipid Mediators in the Brain: The Good, the Bad, and the Ugly Neuroscientist, June 1, 2006; 12(3): 245 - 260. [Abstract] [PDF] |
||||
![]() |
E. S. Musiek, L. Gao, G. L. Milne, W. Han, M. B. Everhart, D. Wang, M. G. Backlund, R. N. DuBois, G. Zanoni, G. Vidari, et al. Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages J. Biol. Chem., October 21, 2005; 280(42): 35562 - 35570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P.J. de Winther, E. Kanters, G. Kraal, and M. H. Hofker Nuclear Factor {kappa}B Signaling in Atherogenesis Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 904 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benderdour, G. Charron, B. Comte, R. Ayoub, D. Beaudry, S. Foisy, D. deBlois, and C. Des Rosiers Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2122 - H2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Quirling, S. Page, N. Jilg, K. Plenagl, D. Peus, C. Grubmuller, M. Weingartner, C. Fischer, D. Neumeier, and K. Brand Detection of IKK{beta}-IKK{gamma} Subcomplexes in Monocytic Cells and Characterization of Associated Signaling J. Biol. Chem., September 3, 2004; 279(36): 37452 - 37460. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chaiswing, M. P. Cole, D. K. St. Clair, W. Ittarat, L. I. Szweda, and T. D. Oberley Oxidative Damage Precedes Nitrative Damage in Adriamycin-Induced Cardiac Mitochondrial Injury Toxicol Pathol, August 1, 2004; 32(5): 536 - 547. [Abstract] [PDF] |
||||
![]() |
Y. Uchida, K.-i. Ohba, T. Yoshioka, K. Irie, T. Muraki, and Y. Maru Cellular Carbonyl Stress Enhances the Expression of Plasminogen Activator Inhibitor-1 in Rat White Adipocytes via Reactive Oxygen Species-dependent Pathway J. Biol. Chem., February 6, 2004; 279(6): 4075 - 4083. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Thukkani, C. J. Albert, K. R. Wildsmith, M. C. Messner, B. D. Martinson, F.-F. Hsu, and D. A. Ford Myeloperoxidase-derived Reactive Chlorinating Species from Human Monocytes Target Plasmalogens in Low Density Lipoprotein J. Biol. Chem., September 19, 2003; 278(38): 36365 - 36372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weber, C. Sydlik, M. Quirling, C. Nothdurfter, A. Zwergal, P. Heiss, S. Bell, D. Neumeier, H. W. L. Ziegler-Heitbrock, and K. Brand Transcriptional Inhibition of Interleukin-8 Expression in Tumor Necrosis Factor-tolerant Cells: EVIDENCE FOR INVOLVEMENT OF C/EBP{beta} J. Biol. Chem., June 20, 2003; 278(26): 23586 - 23593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Vandenplas, R. W. Carlson, B. S. Jeyaretnam, B. McNeill, M. H. Barton, N. Norton, T. F. Murray, and J. N. Moore Rhizobium Sin-1 Lipopolysaccharide (LPS) Prevents Enteric LPS-induced Cytokine Production J. Biol. Chem., October 25, 2002; 277(44): 41811 - 41816. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Luckey, M. Taylor, B. P. Sampey, R. I. Scheinman, and D. R. Petersen 4-Hydroxynonenal Decreases Interleukin-6 Expression and Protein Production in Primary Rat Kupffer Cells by Inhibiting Nuclear Factor-kappa B Activation J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 296 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prebeck, C. Kirschning, S. Durr, C. da Costa, B. Donath, K. Brand, V. Redecke, H. Wagner, and T. Miethke Predominant Role of Toll-Like Receptor 2 Versus 4 in Chlamydia pneumoniae-Induced Activation of Dendritic Cells J. Immunol., September 15, 2001; 167(6): 3316 - 3323. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.T. McGrath, B.M. McGleenon, S. Brennan, D. McColl, S. McILroy, and A.P. Passmore Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde QJM, September 1, 2001; 94(9): 485 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hattori, S. Hattori, and K. Kasai 4-Hydroxynonenal Prevents NO Production in Vascular Smooth Muscle Cells by Inhibiting Nuclear Factor-{kappa}B-Dependent Transcriptional Activation of Inducible NO Synthase Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1179 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Derocq, O. Jbilo, M. Bouaboula, M. Segui, C. Clere, and P. Casellas Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60. POSSIBLE INVOLVEMENT OF THE CB2 RECEPTOR IN CELL DIFFERENTIATION J. Biol. Chem., May 19, 2000; 275(21): 15621 - 15628. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Marnett Oxyradicals and DNA damage Carcinogenesis, March 1, 2000; 21(3): 361 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. F. Refsgaard, L. Tsai, and E. R. Stadtman Modifications of proteins by polyunsaturated fatty acid peroxidation products PNAS, January 18, 2000; 97(2): 611 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fischer, S. Page, M. Weber, T. Eisele, D. Neumeier, and K. Brand Differential Effects of Lipopolysaccharide and Tumor Necrosis Factor on Monocytic Ikappa B Kinase Signalsome Activation and Ikappa B Proteolysis J. Biol. Chem., August 27, 1999; 274(35): 24625 - 24632. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ji, K. R. Kozak, and L. J. Marnett Ikappa B Kinase, a Molecular Target for Inhibition by 4-Hydroxy-2-nonenal J. Biol. Chem., May 18, 2001; 276(21): 18223 - 18228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |